NCT04141969View on ClinicalTrials.gov

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

March 28, 2021

Conditions
Post-Lyme Disease Syndrome (PLDS)
Interventions
DIETARY_SUPPLEMENT

RLP

RLP nutraceutical

OTHER

Placebo

Inert brown powder

Trial Locations (1)

84117

Optimal Health Research, Salt Lake City

All Listed Sponsors
lead

Optimal Health Research

OTHER

NCT04141969 - A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome | Biotech Hunter | Biotech Hunter